Fig. 2From: Systemic RAGE ligands are upregulated in tuberculosis individuals with diabetes co-morbidity and modulated by anti-tuberculosis treatment and metformin therapyTB-DM is associated with increased frequencies of RAGE ligands at pre-treatment and following ATT. The plasma levels of RAGE ligands in TB-DM (n = 44) and TB (n = 44) participants at pre-treatment and at two and six months following ATT. The data are illustrated as scatter plots with each circle representing a single participant. P values were calculated using the Mann-Whitney testBack to article page